Additional Table II from Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial Article Swipe

View

Sara Galimberti , Stefano Luminari , Elena Ciabatti , Susanna Grassi , Francesca Guerrini , Alessandra Dondi , Luigi Marcheselli , Marco Ladetto , Pier Paolo Piccaluga , Anna Gazzola , Claudia Mannu , Luigia Monitillo , Barbara Mantoan , Ilaria Del Giudice , Irene Della Starza , Marzia Cavalli , Luca Arcaini , Alessandra Tucci , Giuseppe Palumbo , Luigi Rigacci , Alessandro Pulsoni , Umberto Vitolo , Carola Boccomini , Daniele Vallisa , Giovanni Bertoldero , Gianluca Gaïdano , Pellegrino Musto , Mario Petrini , Massimo Federico ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1158/1078-0432.22459337.v1

Cox proportional hazard Models for PFS: role of MRD-negativity after 12 month of follow-up.

Related Topics

Concepts

Follicular lymphoma Minimal residual disease Table (database) Residual Oncology Lymphoma Internal medicine Disease Follicular phase Medicine Mathematics Computer science Data mining Leukemia Algorithm

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/1078-0432.22459337.v1
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4361918742

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4361918742

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1078-0432.22459337.v1

Digital Object Identifier
Title: Additional Table II from Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-03-31

Full publication date if available
Authors: Sara Galimberti, Stefano Luminari, Elena Ciabatti, Susanna Grassi, Francesca Guerrini, Alessandra Dondi, Luigi Marcheselli, Marco Ladetto, Pier Paolo Piccaluga, Anna Gazzola, Claudia Mannu, Luigia Monitillo, Barbara Mantoan, Ilaria Del Giudice, Irene Della Starza, Marzia Cavalli, Luca Arcaini, Alessandra Tucci, Giuseppe Palumbo, Luigi Rigacci, Alessandro Pulsoni, Umberto Vitolo, Carola Boccomini, Daniele Vallisa, Giovanni Bertoldero, Gianluca Gaïdano, Pellegrino Musto, Mario Petrini, Massimo Federico

List of authors in order
Landing page: https://doi.org/10.1158/1078-0432.22459337.v1

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/1078-0432.22459337.v1

Direct OA link when available
Concepts: Follicular lymphoma, Minimal residual disease, Table (database), Residual, Oncology, Lymphoma, Internal medicine, Disease, Follicular phase, Medicine, Mathematics, Computer science, Data mining, Leukemia, Algorithm

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4361918742
doi	https://doi.org/10.1158/1078-0432.22459337.v1
ids.doi	https://doi.org/10.1158/1078-0432.22459337.v1
ids.openalex	https://openalex.org/W4361918742
fwci	0.0
type	preprint
title	Additional Table II from Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T10185
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9991999864578247
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2734
topics[0].subfield.display_name	Pathology and Forensic Medicine
topics[0].display_name	Lymphoma Diagnosis and Treatment
topics[1].id	https://openalex.org/T11157
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9405999779701233
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2716
topics[1].subfield.display_name	Genetics
topics[1].display_name	Chronic Lymphocytic Leukemia Research
topics[2].id	https://openalex.org/T10417
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9300000071525574
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2740
topics[2].subfield.display_name	Pulmonary and Respiratory Medicine
topics[2].display_name	Lung Cancer Treatments and Mutations
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C2777058707
concepts[0].level	3
concepts[0].score	0.8742249011993408
concepts[0].wikidata	https://www.wikidata.org/wiki/Q123251
concepts[0].display_name	Follicular lymphoma
concepts[1].id	https://openalex.org/C2779823535
concepts[1].level	3
concepts[1].score	0.6727907657623291
concepts[1].wikidata	https://www.wikidata.org/wiki/Q6865356
concepts[1].display_name	Minimal residual disease
concepts[2].id	https://openalex.org/C45235069
concepts[2].level	2
concepts[2].score	0.6418010592460632
concepts[2].wikidata	https://www.wikidata.org/wiki/Q278425
concepts[2].display_name	Table (database)
concepts[3].id	https://openalex.org/C155512373
concepts[3].level	2
concepts[3].score	0.6300513744354248
concepts[3].wikidata	https://www.wikidata.org/wiki/Q287450
concepts[3].display_name	Residual
concepts[4].id	https://openalex.org/C143998085
concepts[4].level	1
concepts[4].score	0.5348787307739258
concepts[4].wikidata	https://www.wikidata.org/wiki/Q162555
concepts[4].display_name	Oncology
concepts[5].id	https://openalex.org/C2779338263
concepts[5].level	2
concepts[5].score	0.5232983231544495
concepts[5].wikidata	https://www.wikidata.org/wiki/Q208414
concepts[5].display_name	Lymphoma
concepts[6].id	https://openalex.org/C126322002
concepts[6].level	1
concepts[6].score	0.47409185767173767
concepts[6].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[6].display_name	Internal medicine
concepts[7].id	https://openalex.org/C2779134260
concepts[7].level	2
concepts[7].score	0.46737995743751526
concepts[7].wikidata	https://www.wikidata.org/wiki/Q12136
concepts[7].display_name	Disease
concepts[8].id	https://openalex.org/C187785154
concepts[8].level	2
concepts[8].score	0.4499198794364929
concepts[8].wikidata	https://www.wikidata.org/wiki/Q5464664
concepts[8].display_name	Follicular phase
concepts[9].id	https://openalex.org/C71924100
concepts[9].level	0
concepts[9].score	0.4408606290817261
concepts[9].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[9].display_name	Medicine
concepts[10].id	https://openalex.org/C33923547
concepts[10].level	0
concepts[10].score	0.20714017748832703
concepts[10].wikidata	https://www.wikidata.org/wiki/Q395
concepts[10].display_name	Mathematics
concepts[11].id	https://openalex.org/C41008148
concepts[11].level	0
concepts[11].score	0.14252838492393494
concepts[11].wikidata	https://www.wikidata.org/wiki/Q21198
concepts[11].display_name	Computer science
concepts[12].id	https://openalex.org/C124101348
concepts[12].level	1
concepts[12].score	0.06645527482032776
concepts[12].wikidata	https://www.wikidata.org/wiki/Q172491
concepts[12].display_name	Data mining
concepts[13].id	https://openalex.org/C2778461978
concepts[13].level	2
concepts[13].score	0.0638786256313324
concepts[13].wikidata	https://www.wikidata.org/wiki/Q29496
concepts[13].display_name	Leukemia
concepts[14].id	https://openalex.org/C11413529
concepts[14].level	1
concepts[14].score	0.0
concepts[14].wikidata	https://www.wikidata.org/wiki/Q8366
concepts[14].display_name	Algorithm
keywords[0].id	https://openalex.org/keywords/follicular-lymphoma
keywords[0].score	0.8742249011993408
keywords[0].display_name	Follicular lymphoma
keywords[1].id	https://openalex.org/keywords/minimal-residual-disease
keywords[1].score	0.6727907657623291
keywords[1].display_name	Minimal residual disease
keywords[2].id	https://openalex.org/keywords/table
keywords[2].score	0.6418010592460632
keywords[2].display_name	Table (database)
keywords[3].id	https://openalex.org/keywords/residual
keywords[3].score	0.6300513744354248
keywords[3].display_name	Residual
keywords[4].id	https://openalex.org/keywords/oncology
keywords[4].score	0.5348787307739258
keywords[4].display_name	Oncology
keywords[5].id	https://openalex.org/keywords/lymphoma
keywords[5].score	0.5232983231544495
keywords[5].display_name	Lymphoma
keywords[6].id	https://openalex.org/keywords/internal-medicine
keywords[6].score	0.47409185767173767
keywords[6].display_name	Internal medicine
keywords[7].id	https://openalex.org/keywords/disease
keywords[7].score	0.46737995743751526
keywords[7].display_name	Disease
keywords[8].id	https://openalex.org/keywords/follicular-phase
keywords[8].score	0.4499198794364929
keywords[8].display_name	Follicular phase
keywords[9].id	https://openalex.org/keywords/medicine
keywords[9].score	0.4408606290817261
keywords[9].display_name	Medicine
keywords[10].id	https://openalex.org/keywords/mathematics
keywords[10].score	0.20714017748832703
keywords[10].display_name	Mathematics
keywords[11].id	https://openalex.org/keywords/computer-science
keywords[11].score	0.14252838492393494
keywords[11].display_name	Computer science
keywords[12].id	https://openalex.org/keywords/data-mining
keywords[12].score	0.06645527482032776
keywords[12].display_name	Data mining
keywords[13].id	https://openalex.org/keywords/leukemia
keywords[13].score	0.0638786256313324
keywords[13].display_name	Leukemia
language	en
locations[0].id	doi:10.1158/1078-0432.22459337.v1
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1078-0432.22459337.v1
locations[1].id	pmh:oai:figshare.com:article/22459337
locations[1].is_oa	True
locations[1].source.id	https://openalex.org/S4306400572
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	OPAL (Open@LaTrobe) (La Trobe University)
locations[1].source.host_organization	https://openalex.org/I196829312
locations[1].source.host_organization_name	La Trobe University
locations[1].source.host_organization_lineage	https://openalex.org/I196829312
locations[1].license	cc-by
locations[1].pdf_url
locations[1].version	submittedVersion
locations[1].raw_type	Text
locations[1].license_id	https://openalex.org/licenses/cc-by
locations[1].is_accepted	False
locations[1].is_published	False
locations[1].raw_source_name
locations[1].landing_page_url	https://figshare.com/articles/journal_contribution/Additional_Table_II_from_Minimal_Residual_Disease_after_Conventional_Treatment_Significantly_Impacts_on_Progression-Free_Survival_of_Patients_with_Follicular_Lymphoma_The_FIL_FOLL05_Trial/22459337
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5001285087
authorships[0].author.orcid	https://orcid.org/0000-0002-4620-0038
authorships[0].author.display_name	Sara Galimberti
authorships[0].author_position	first
authorships[0].raw_author_name	Sara Galimberti
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5016803459
authorships[1].author.orcid	https://orcid.org/0000-0001-8446-2285
authorships[1].author.display_name	Stefano Luminari
authorships[1].author_position	middle
authorships[1].raw_author_name	Stefano Luminari
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5029614391
authorships[2].author.orcid
authorships[2].author.display_name	Elena Ciabatti
authorships[2].author_position	middle
authorships[2].raw_author_name	Elena Ciabatti
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5111733149
authorships[3].author.orcid
authorships[3].author.display_name	Susanna Grassi
authorships[3].author_position	middle
authorships[3].raw_author_name	Susanna Grassi
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5112037714
authorships[4].author.orcid
authorships[4].author.display_name	Francesca Guerrini
authorships[4].author_position	middle
authorships[4].raw_author_name	Francesca Guerrini
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5005899608
authorships[5].author.orcid
authorships[5].author.display_name	Alessandra Dondi
authorships[5].author_position	middle
authorships[5].raw_author_name	Alessandra Dondi
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5070490189
authorships[6].author.orcid
authorships[6].author.display_name	Luigi Marcheselli
authorships[6].author_position	middle
authorships[6].raw_author_name	Luigi Marcheselli
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5076353357
authorships[7].author.orcid	https://orcid.org/0000-0002-8283-2681
authorships[7].author.display_name	Marco Ladetto
authorships[7].author_position	middle
authorships[7].raw_author_name	Marco Ladetto
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5037413392
authorships[8].author.orcid	https://orcid.org/0000-0002-9432-0595
authorships[8].author.display_name	Pier Paolo Piccaluga
authorships[8].author_position	middle
authorships[8].raw_author_name	Pier Paolo Piccaluga
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5066783477
authorships[9].author.orcid	https://orcid.org/0000-0001-8131-7170
authorships[9].author.display_name	Anna Gazzola
authorships[9].author_position	middle
authorships[9].raw_author_name	Anna Gazzola
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5004960762
authorships[10].author.orcid
authorships[10].author.display_name	Claudia Mannu
authorships[10].author_position	middle
authorships[10].raw_author_name	Claudia Mannu
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5036916107
authorships[11].author.orcid
authorships[11].author.display_name	Luigia Monitillo
authorships[11].author_position	middle
authorships[11].raw_author_name	Luigia Monitillo
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5079136601
authorships[12].author.orcid
authorships[12].author.display_name	Barbara Mantoan
authorships[12].author_position	middle
authorships[12].raw_author_name	Barbara Mantoan
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5034415866
authorships[13].author.orcid	https://orcid.org/0000-0001-6864-9533
authorships[13].author.display_name	Ilaria Del Giudice
authorships[13].author_position	middle
authorships[13].raw_author_name	Ilaria Del Giudice
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5069193615
authorships[14].author.orcid	https://orcid.org/0000-0001-7909-8642
authorships[14].author.display_name	Irene Della Starza
authorships[14].author_position	middle
authorships[14].raw_author_name	Irene Della Starza
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5037764279
authorships[15].author.orcid	https://orcid.org/0000-0002-2773-5483
authorships[15].author.display_name	Marzia Cavalli
authorships[15].author_position	middle
authorships[15].raw_author_name	Marzia Cavalli
authorships[15].is_corresponding	False
authorships[16].author.id	https://openalex.org/A5019034145
authorships[16].author.orcid	https://orcid.org/0000-0002-9504-991X
authorships[16].author.display_name	Luca Arcaini
authorships[16].author_position	middle
authorships[16].raw_author_name	Luca Arcaini
authorships[16].is_corresponding	False
authorships[17].author.id	https://openalex.org/A5076236981
authorships[17].author.orcid	https://orcid.org/0000-0003-3052-7463
authorships[17].author.display_name	Alessandra Tucci
authorships[17].author_position	middle
authorships[17].raw_author_name	Alessandra Tucci
authorships[17].is_corresponding	False
authorships[18].author.id	https://openalex.org/A5078005763
authorships[18].author.orcid	https://orcid.org/0000-0002-1010-2946
authorships[18].author.display_name	Giuseppe Palumbo
authorships[18].author_position	middle
authorships[18].raw_author_name	Giuseppe Alberto Palumbo
authorships[18].is_corresponding	False
authorships[19].author.id	https://openalex.org/A5089632360
authorships[19].author.orcid	https://orcid.org/0000-0002-9320-9334
authorships[19].author.display_name	Luigi Rigacci
authorships[19].author_position	middle
authorships[19].raw_author_name	Luigi Rigacci
authorships[19].is_corresponding	False
authorships[20].author.id	https://openalex.org/A5081247845
authorships[20].author.orcid	https://orcid.org/0000-0001-7429-8004
authorships[20].author.display_name	Alessandro Pulsoni
authorships[20].author_position	middle
authorships[20].raw_author_name	Alessandro Pulsoni
authorships[20].is_corresponding	False
authorships[21].author.id	https://openalex.org/A5000403848
authorships[21].author.orcid	https://orcid.org/0000-0001-7772-2747
authorships[21].author.display_name	Umberto Vitolo
authorships[21].author_position	middle
authorships[21].raw_author_name	Umberto Vitolo
authorships[21].is_corresponding	False
authorships[22].author.id	https://openalex.org/A5033131356
authorships[22].author.orcid	https://orcid.org/0000-0002-4155-403X
authorships[22].author.display_name	Carola Boccomini
authorships[22].author_position	middle
authorships[22].raw_author_name	Carola Boccomini
authorships[22].is_corresponding	False
authorships[23].author.id	https://openalex.org/A5047971271
authorships[23].author.orcid	https://orcid.org/0000-0002-3130-1979
authorships[23].author.display_name	Daniele Vallisa
authorships[23].author_position	middle
authorships[23].raw_author_name	Daniele Vallisa
authorships[23].is_corresponding	False
authorships[24].author.id	https://openalex.org/A5031900268
authorships[24].author.orcid
authorships[24].author.display_name	Giovanni Bertoldero
authorships[24].author_position	middle
authorships[24].raw_author_name	Giovanni Bertoldero
authorships[24].is_corresponding	False
authorships[25].author.id	https://openalex.org/A5041745367
authorships[25].author.orcid	https://orcid.org/0000-0002-4681-0151
authorships[25].author.display_name	Gianluca Gaïdano
authorships[25].author_position	middle
authorships[25].raw_author_name	Gianluca Gaidano
authorships[25].is_corresponding	False
authorships[26].author.id	https://openalex.org/A5044869604
authorships[26].author.orcid	https://orcid.org/0000-0003-3277-6594
authorships[26].author.display_name	Pellegrino Musto
authorships[26].author_position	middle
authorships[26].raw_author_name	Pellegrino Musto
authorships[26].is_corresponding	False
authorships[27].author.id	https://openalex.org/A5072006834
authorships[27].author.orcid	https://orcid.org/0000-0002-1017-6961
authorships[27].author.display_name	Mario Petrini
authorships[27].author_position	middle
authorships[27].raw_author_name	Mario Petrini
authorships[27].is_corresponding	False
authorships[28].author.id	https://openalex.org/A5035398527
authorships[28].author.orcid	https://orcid.org/0000-0002-9889-3796
authorships[28].author.display_name	Massimo Federico
authorships[28].author_position	last
authorships[28].raw_author_name	Massimo Federico
authorships[28].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/1078-0432.22459337.v1
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Additional Table II from Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10185
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9991999864578247
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2734
primary_topic.subfield.display_name	Pathology and Forensic Medicine
primary_topic.display_name	Lymphoma Diagnosis and Treatment
related_works	https://openalex.org/W2140133829, https://openalex.org/W2140867490, https://openalex.org/W1552123239, https://openalex.org/W2103709767, https://openalex.org/W2147384423, https://openalex.org/W2114797872, https://openalex.org/W3005250590, https://openalex.org/W71987001, https://openalex.org/W4247181542, https://openalex.org/W2035782146
cited_by_count	0
locations_count	2
best_oa_location.id	doi:10.1158/1078-0432.22459337.v1
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1078-0432.22459337.v1
primary_location.id	doi:10.1158/1078-0432.22459337.v1
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1078-0432.22459337.v1
publication_date	2023-03-31
publication_year	2023
referenced_works_count	0
abstract_inverted_index.12	10
abstract_inverted_index.of	7, 12
abstract_inverted_index.for	4
abstract_inverted_index.PFS:	5
abstract_inverted_index.role	6
abstract_inverted_index.after	9
abstract_inverted_index.month	11
abstract_inverted_index.Models	3
abstract_inverted_index.hazard	2
abstract_inverted_index.<p>Cox	0
abstract_inverted_index.proportional	1
abstract_inverted_index.MRD-negativity	8
abstract_inverted_index.follow-up.</p>	13
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	29
citation_normalized_percentile.value	0.09489129
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False